ST. PAUL, Minn. & AUSTIN, Texas--(BUSINESS WIRE)--BioE®, Inc., a biomedical company that provides enabling, high-quality cellular tools for drug discovery and therapeutic research, and The University of Texas M. D. Anderson Cancer Center announced today a research partnership to evaluate the potential of BioE’s cord blood stem cell — the Multi-Lineage Progenitor Cell™ (MLPC™) — to help treat cancer.
